Intervention
Zidovudine
ClinicalTrials.gov intervention label
Clinical trials
60 shownNatural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)NCT01419561 · 2011-09-08
RECRUITINGNucleosides And Darunavir/Dolutegravir In AfricaNCT03988452 · 2019-07-30
UNKNOWNStudy of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, BotswanaNCT03088410 · 2016-08-22
COMPLETEDAntiretroviral Regime for Viral Eradication in NewbornsNCT02712801 · 2016-04-01
COMPLETEDLatency and Early Neonatal Provision of Antiretroviral Drugs Clinical TrialNCT02431975 · 2015-08-01
COMPLETEDEarly Infant HIV Treatment in BotswanaNCT02369406 · 2015-05-04
ACTIVE_NOT_RECRUITINGEconomic, Clinical and Quality of Life Assessment in Patients on Antiretroviral TherapyNCT01694017 · 2012-11-01
COMPLETEDHuman Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)NCT01516970 · 2011-11-25
COMPLETEDTocilizumab for KSHV-Associated Multicentric Castleman DiseaseNCT01441063 · 2011-09-13
COMPLETEDSafety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected PatientsNCT01540240 · 2011-08-01
UNKNOWNA Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 YearsNCT00799864 · 2011-01-01
COMPLETEDProtease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant WomenNCT00993031 · 2009-12-15
COMPLETEDDifferences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAARTNCT00719602 · 2009-08-01
COMPLETEDDetermining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected AdultsNCT00608569 · 2009-03-01
COMPLETEDSafety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in ThailandNCT00672412 · 2008-10-01
COMPLETEDSafety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected ChildrenNCT00528957 · 2006-12-28
COMPLETEDReducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving BirthNCT00109590 · 2006-06-01
COMPLETEDWhen to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)NCT00234091 · 2006-04-01
COMPLETEDAntiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIVNCT00307151 · 2005-12-01
COMPLETEDAnti-HIV Drugs for Treating Infants Who Acquired HIV Infection at BirthNCT00102960 · 2005-07-01
COMPLETEDVirotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityNCT00092222 · 2004-10-28
ACTIVE_NOT_RECRUITINGAnti-HIV Drugs for Ugandan Patients With HIV and TuberculosisNCT00078247 · 2004-10-01
COMPLETEDTrial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV TransmissionNCT00099359 · 2004-02-01
COMPLETEDAntiretroviral Therapy for Advanced HIV Disease in South AfricaNCT00342355 · 2004-01-01
COMPLETEDOpen Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIVNCT00144157 · 2003-06-01
COMPLETEDBioequivalency Study of Zidovudine Under Fed ConditionsNCT00601562 · 2003-06-01
COMPLETEDBioequivalency Study of Zidovudine Under Fasting ConditionsNCT00602550 · 2003-06-01
COMPLETEDHIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)NCT00192660 · 2003-02-01
COMPLETEDCombination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During PregnancyNCT00017719 · 2002-05-01
COMPLETEDTrial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric PatientsNCT00273975 · 2002-01-01
COMPLETEDTreatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV DrugsNCT00005000 · 1999-12-01
UNKNOWNEffects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIVNCT00001119 · 1999-10-01
COMPLETEDSafety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV DrugsNCT00004852 · 1999-09-01
COMPLETEDA Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV DrugsNCT00002411 · 1998-03-01
COMPLETEDUse of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV InfectionNCT00001644 · 1997-03-03
COMPLETEDThe Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken ZidovudineNCT00002371 · 1996-06-01
COMPLETEDA Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected PatientsNCT00002401
COMPLETEDThe Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDSNCT00000971
COMPLETEDSafety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic IndividualsNCT00000664
COMPLETEDThe Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected PatientNCT00000661
COMPLETEDA Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV InfectionNCT00000760
COMPLETEDThe Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.NCT00000629
COMPLETEDThe Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of InfectionNCT00001036
COMPLETEDA Pharmacokinetic Study of L-697,661 Alone and in Combination With ZidovudineNCT00000628
COMPLETEDAn Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)NCT00000649
COMPLETEDEvaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.NCT00000818
COMPLETEDA Study of Zidovudine in Infants Exposed to the HIV Before or Soon After BirthNCT00001007
COMPLETEDA Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected PatientsNCT00002168
COMPLETEDA Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsNCT00002369
COMPLETEDA Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the PastNCT00002320
COMPLETEDAn Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2NCT00002023
COMPLETEDThe Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected PatientsNCT00002376
COMPLETEDThe Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of InfectionNCT00002179
COMPLETEDThe Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZTNCT00002436
COMPLETEDThe Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV DrugsNCT00002379
COMPLETEDA Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected PatientsNCT00002195
COMPLETEDA Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected PatientsNCT00001085
COMPLETEDA Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 InfectionNCT00002270
COMPLETEDA Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC PatientsNCT00002013
COMPLETEDThe Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous SystemNCT00002288
COMPLETEDCommon conditions
HIV Infections252Pregnancy10HIV7Sarcoma, Kaposi7AIDS Dementia Complex5Cytopenias5Cytomegalovirus Retinitis3Hemophilia A3Lymphoma, Non-Hodgkin3Pneumonia, Pneumocystis Carinii3Cytomegalovirus Infections2HHV-82Leukoencephalopathy, Progressive Multifocal2Malaria2Tuberculosis2Acquired Immunodeficiency Syndrome1Cardiovascular Disease1Castleman Disease1Diabetes Mellitus1Disease Transmission, Vertical1Encephalopathies1Giant Lymph Node Hyperplasia1Hepatitis C1HIV Infection1HIV-11
Leading sponsors
National Institute of Allergy and Infectious Diseases (NIAID)158Glaxo Wellcome26Hoffmann-La Roche10Merck Sharp & Dohme LLC7Bristol-Myers Squibb6Pharmacia and Upjohn6Boehringer Ingelheim5Gilead Sciences4National Cancer Institute (NCI)4Sandoz3Amgen2Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2G D Searle2International Maternal Pediatric Adolescent AIDS Clinical Trials Group2Roxane Laboratories2
Trial status mix
COMPLETED257
TERMINATED4
UNKNOWN3
ACTIVE_NOT_RECRUITING2
RECRUITING1
WITHDRAWN1
Phase mix
NA74
PHASE271
PHASE166
PHASE348
PHASE411
EARLY_PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.